Crabel Capital Management, LLC Eli Lilly & CO Transaction History

Crabel Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $492,033 - $608,997	-4,133 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $30,579 - $37,874	-286 Reduced 6.47%	4,133 $543,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $471,905 - $513,311	4,419 New	4,419 $494,000
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $217,054 - $271,279	-2,528 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$75.7 - $86.88 $191,369 - $219,632	2,528 New	2,528 $216,000

3,722

738M

7.09M

7.24M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Crabel Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Crabel Capital Management, LLC with notifications on news.